A team of researchers from the MRC Weatherall Institute of Molecular Medicine at Oxford University has developed a new technique that allows scientists to reliably track genetic errors in individual cancer cells, and find ...
Feb 12, 2019
1
11
A brand new type of cancer drug that acts as a 'Trojan horse' to get inside tumour cells has shown promise in patients with six different cancer types.
Feb 7, 2019
0
720
A new 'seek-and-destroy' gene therapeutic system could have the potential to treat prostate cancer in the future, after it halted the majority of tumours in laboratory models at the University of Strathclyde and the Beatson ...
Feb 4, 2019
0
0
Acinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gland tissue and occur most frequently in the parotid gland. Until now, the molecular causes ...
Jan 31, 2019
0
24
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical ...
Jan 29, 2019
0
5
Scientists have identified genetic changes that may predict the likelihood of breast cancer relapse in women taking a common type of hormone therapy.
Jan 22, 2019
0
6
Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) in tumours can be targeted to prevent and treat cancer. Together with collaborators from the United States ...
Jan 22, 2019
0
3
Epstein-Barr virus infects more than 95 percent of people, usually without symptoms. But sometimes its persistence in cells can lead to tumour formation. Now, researchers from Hong Kong and the UK have developed a fluorescing, ...
Jan 18, 2019
0
23
Unlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despite being a well-known cause of therapy resistance and metastasis, ...
Jan 14, 2019
0
32
The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with ...
Jan 8, 2019
0
4
